“Using Regression Trees to Predict the Development of Immune-Mediated Adverse Events in Patients Receiving Immune Checkpoint Inhibitor Therapy” (2024) Voprosy onkologii, 70(4), pp. 677–684. doi:10.37469/0507-3758-2024-70-4-677-684.